Is there a need to control the placebo in placebo controlled trials?

被引：8
作者：
DeCraen, AJM
Tijssen, JGP
Kleijnen, J
机构：
来源：
HEART | 1997年 / 77卷 / 02期
关键词：
D O I：
10.1136/hrt.77.2.95
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：95 / 96
页数：2
相关论文
共 21 条
[1]   CONTROLLED TRIAL OF CLOFIBRATE IN CEREBRAL VASCULAR-DISEASE [J].
ACHESON, J ;
HUTCHINSON, EC .
ATHEROSCLEROSIS, 1972, 15 (02) :177-+
[2]  
[Anonymous], 1988, LANCET, V2, P349
[3]  
[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
[4]  
[Anonymous], 1971, Br Med J
[5]  
[Anonymous], BR MED J
[6]   CONFUSION OVER USE OF PLACEBOS IN CLINICAL-TRIALS - BETTER GUIDELINES NEEDED [J].
COLLIER, J .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7009) :821-822
[7]  
COLLINS R, 1995, LANCET, V345, P669
[8]   BLEAK OUTLOOK FOR PLACEBOS (AND FOR SCIENCE) [J].
DOLLERY, CT .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (04) :219-221
[9]  
FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707
[10]   AN EVIDENCE BASED APPROACH TO INDIVIDUALIZING TREATMENT [J].
GLASZIOU, PP ;
IRWIG, LM .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7016) :1356-1359
123